Major depressive disorder (MDD) is a debilitating psychiatric condition characterized by a persistently low mood, a lack of motivation, feelings of hopelessness, altered sleeping and/or eating patterns, and a reduced interest ...
If you scroll through TikTok or Instagram long enough, you'll inevitably stumble across the line: "Your frontal lobe isn't fully developed yet." It's become neuroscience's go-to explanation for bad decisions, like ordering ...
3 hours ago
0
0
Tanning bed users are known to have a higher risk of skin cancer, but for the first time researchers have found that young indoor tanners undergo genetic changes that can lead to more mutations in their skin cells than people ...
6 hours ago
0
6
The best way for people with depression to stop taking antidepressants once their condition improves is to slowly taper off the medication while also receiving psychological support, new research suggested Thursday.
8 hours ago
0
44
The human brain is a fascinating and complex organ that supports numerous sophisticated behaviors and abilities that are observed in no other animal species. For centuries, scientists have been trying to understand what is ...
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match ...
Dec 26, 2025
0
41
The digital revolution has become a vast, unplanned experiment—and children are its most exposed participants. As ADHD diagnoses rise around the world, a key question has emerged: could the growing use of digital devices ...
Dec 26, 2025
0
59
Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients remain wary of side effects or uneasy about taking a daily pill.
Dec 26, 2025
0
2
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal cancer, which is more ...
Dec 25, 2025
0
27
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established in 2024 for TRBC1-positive ...
Dec 25, 2025
0
86
